133 related articles for article (PubMed ID: 12358895)
1. Cost-effective use of liposomal amphotericin B.
O'Connell B; Craig JI; Marcus RE; Ludlam H
Clin Lab Haematol; 2002 Oct; 24(5):317-9. PubMed ID: 12358895
[No Abstract] [Full Text] [Related]
2. Liposomal amphotericin B for fever and neutropenia.
Winston DJ; Schiller GJ; Territo MC
N Engl J Med; 1999 Oct; 341(15):1154-5. PubMed ID: 10515755
[No Abstract] [Full Text] [Related]
3. Liposomal amphotericin B for fever and neutropenia.
Rakita R
N Engl J Med; 1999 Oct; 341(15):1153-4; author reply 1154-5. PubMed ID: 10515754
[No Abstract] [Full Text] [Related]
4. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
[TBL] [Abstract][Full Text] [Related]
5. Lipid formulations of amphotericin B.
Dix SP; Andriole VT
Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516
[TBL] [Abstract][Full Text] [Related]
6. Reply: Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
Huprikar S
Liver Transpl; 2008 May; 14(5):709. PubMed ID: 18433053
[No Abstract] [Full Text] [Related]
7. Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections?
Schneemann M; Bachli EB
Clin Infect Dis; 2004 Jan; 38(2):303-4; author reply 306-7. PubMed ID: 14699468
[No Abstract] [Full Text] [Related]
8. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases.
Dornbusch HJ; Urban CE; Pinter H; Ginter G; Fotter R; Becker H; Miorini T; Berghold C
Pediatr Hematol Oncol; 1995; 12(6):577-86. PubMed ID: 8589003
[TBL] [Abstract][Full Text] [Related]
9. Experience with liposomal amphotericin B at the Hematology-Oncology Department Children's Hospital Salata Medical School, University of Zagreb.
Konja J; Glavas B; Anicić M
Acta Biomed; 2006; 77 Suppl 2():14-6. PubMed ID: 16918061
[TBL] [Abstract][Full Text] [Related]
10. Treatment of deep mycoses with liposomal amphotericin B.
Berenguer J; Muñoz P; Parras F; Fernández-Baca V; Hernández-Sampelayo T; Bouza E
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):504-7. PubMed ID: 7957273
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B in three lung transplant recipients. The Groningen Lung Transplantation Group.
Mannes GP; van der Bij W; de Boer WJ
J Heart Lung Transplant; 1995; 14(4):781-4. PubMed ID: 7578189
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever.
Wingard JR; Leather HL; Wood CA; Gerth WC; Lupinacci RJ; Berger ML; Mansley EC
Am J Health Syst Pharm; 2007 Mar; 64(6):637-43. PubMed ID: 17353573
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.
Flynn TN; Kelsey SM; Hazel DL; Guest JF
Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):543-50. PubMed ID: 10662479
[TBL] [Abstract][Full Text] [Related]
14. The use of liposomal amphotericin B in the treatment of neutropenia-associated fungal infections: efficacy and cost-effectiveness.
Newland AC
Br J Haematol; 1999 Feb; 104(2):425-6. PubMed ID: 10050732
[No Abstract] [Full Text] [Related]
15. Liposomal amphotericin B for fever and neutropenia.
Fischer T; Heussel G; Huber C
N Engl J Med; 1999 Oct; 341(15):1152; author reply 1154-5. PubMed ID: 10515750
[No Abstract] [Full Text] [Related]
16. Is liposomal amphotericin B (ambisome) an effective prophylaxis of mycotic infections after liver transplantation?
Braun F; Rüchel R; Lorf T; Canelo R; Müller A; Sattler B; Ringe B
Transplant Proc; 1998 Jun; 30(4):1481-3. PubMed ID: 9636602
[No Abstract] [Full Text] [Related]
17. Liposomal amphotericin B for fever and neutropenia.
Prentice HG; Kibbler CC
N Engl J Med; 1999 Oct; 341(15):1152-3; author reply 1154-5. PubMed ID: 10515751
[No Abstract] [Full Text] [Related]
18. Case reports. Invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B.
Zhirong Y; Wanqing L; Weihua P
Mycoses; 1999; 42(11-12):679-82. PubMed ID: 10680448
[TBL] [Abstract][Full Text] [Related]
19. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
[TBL] [Abstract][Full Text] [Related]
20. Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.
Krupova Y; Mistrik M; Bojtarova E; Sejnova D; Ilavska I; Krcmery V
Support Care Cancer; 2001 May; 9(3):209-10. PubMed ID: 11401107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
